e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neurogene Inc. - Common Stock
(NQ:
NGNE
)
27.10
-0.61 (-2.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neurogene Inc. - Common Stock
< Previous
1
2
3
4
Next >
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
March 18, 2024
From
Neurogene Inc.
Via
Business Wire
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial
March 04, 2024
From
Neurogene Inc.
Via
Business Wire
Neurogene to Participate in Upcoming Investor Conferences
February 29, 2024
From
Neurogene Inc.
Via
Business Wire
MicroMarvel Neurogene Challenges Big Pharma
↗
January 22, 2024
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases.
Via
Talk Markets
Neurogene Announces Appointment of Julie Jordan, M.D., as Chief Medical Officer
January 16, 2024
From
Neurogene Inc.
Via
Business Wire
Neurogene Announces Business Update and 2024 Outlook
January 05, 2024
From
Neurogene Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.